<?xml version='1.0' encoding='UTF-8'?><?xml-stylesheet href="http://www.blogger.com/styles/atom.css" type="text/css"?><feed xmlns='http://www.w3.org/2005/Atom' xmlns:openSearch='http://a9.com/-/spec/opensearchrss/1.0/' xmlns:georss='http://www.georss.org/georss' xmlns:gd='http://schemas.google.com/g/2005' xmlns:thr='http://purl.org/syndication/thread/1.0'><id>tag:blogger.com,1999:blog-4134568493372182092</id><updated>2011-07-28T22:15:30.653-07:00</updated><title type='text'>Conferencias y presentaciones</title><subtitle type='html'>Por Mauricio Lema Medina</subtitle><link rel='http://schemas.google.com/g/2005#feed' type='application/atom+xml' href='http://mlmconferencias.blogspot.com/feeds/posts/default'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default?max-results=100'/><link rel='alternate' type='text/html' href='http://mlmconferencias.blogspot.com/'/><link rel='hub' href='http://pubsubhubbub.appspot.com/'/><author><name>Mauricio Lema Medina MD</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='24' src='http://1.bp.blogspot.com/_y9jkl9x1Ivo/Ska2ADzwPoI/AAAAAAAABeM/tibbbu8yvdk/S220/MLM27062009.jpg'/></author><generator version='7.00' uri='http://www.blogger.com'>Blogger</generator><openSearch:totalResults>18</openSearch:totalResults><openSearch:startIndex>1</openSearch:startIndex><openSearch:itemsPerPage>100</openSearch:itemsPerPage><entry><id>tag:blogger.com,1999:blog-4134568493372182092.post-5925495789106167910</id><published>2010-01-17T07:45:00.001-08:00</published><updated>2010-01-17T07:45:42.525-08:00</updated><title type='text'>Capacitaciones en cáncer de colon y recto y NSCLC</title><content type='html'>Producto: Capacitación Cáncer de Colon y Recto metastásico.&lt;br /&gt;Tiempo: 10 horas.&lt;br /&gt;Énfasis: Terapia dirigida.&lt;br /&gt;Primer entrenamiento: 30/09/2009.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.esnips.com/doc/c6405819-cfc0-4617-8611-b0e16524a43f/AVASTIN_en_mCRC_2009_Roche_Modulo_Capacitación"&gt;Documento maestro&lt;/a&gt; (ppt 97-2003, 30 MB)&lt;br /&gt;&lt;br /&gt;Producto: Capacitación cáncer de células no pequeñas metastásico&lt;br /&gt;Tiempo: 10 horas.&lt;br /&gt;Énfasis: Terapia dirigida.&lt;br /&gt;Primer entrenamiento: 25/10/2009.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.esnips.com/doc/2ce456f0-2f3b-43ac-a6a1-76176f714888/mNSCLC_2009_Roche_Modulo_Global"&gt;Documento maestro&lt;/a&gt; (ppt 97-2003, 26 MB)&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4134568493372182092-5925495789106167910?l=mlmconferencias.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://mlmconferencias.blogspot.com/feeds/5925495789106167910/comments/default' title='Enviar comentarios'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4134568493372182092&amp;postID=5925495789106167910' title='0 comentarios'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/5925495789106167910'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/5925495789106167910'/><link rel='alternate' type='text/html' href='http://mlmconferencias.blogspot.com/2010/01/capacitaciones-en-cancer-de-colon-y.html' title='Capacitaciones en cáncer de colon y recto y NSCLC'/><author><name>Mauricio Lema Medina MD</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='24' src='http://1.bp.blogspot.com/_y9jkl9x1Ivo/Ska2ADzwPoI/AAAAAAAABeM/tibbbu8yvdk/S220/MLM27062009.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4134568493372182092.post-469930267998309274</id><published>2009-11-26T09:28:00.001-08:00</published><updated>2009-11-26T14:50:03.897-08:00</updated><title type='text'>Terapia sistémica en Cáncer de Colon y Recto Metastásico</title><content type='html'>&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://4.bp.blogspot.com/_y9jkl9x1Ivo/Sw663VgWakI/AAAAAAAABtQ/kIgkSnXTmVA/s1600/mCRC_Bogot%C3%A1_2511200901.jpg"&gt;&lt;img style="cursor:pointer; cursor:hand;width: 288px; height: 400px;" src="http://4.bp.blogspot.com/_y9jkl9x1Ivo/Sw663VgWakI/AAAAAAAABtQ/kIgkSnXTmVA/s400/mCRC_Bogot%C3%A1_2511200901.jpg" border="0" alt=""id="BLOGGER_PHOTO_ID_5408465662346947138" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;strong&gt;Fecha y lugar&lt;/strong&gt;: 23 de Noviembre 2009 - Cali (Restaurante San Joaquín), 25 de Noviembre de 2009 - Bogotá (Hotel Cosmos 100).&lt;br /&gt;&lt;strong&gt;Evento&lt;/strong&gt;: Presentación de la evidencia en terapia sistémica en cáncer de colon y recto metastásico: citostáticos, monoclonales, estrategias de curación.&lt;br /&gt;&lt;strong&gt;Conferencia&lt;/strong&gt;: Terapia sistémica en cáncer de colon y recto metastásico.&lt;br /&gt;&lt;strong&gt;Auspiciado por&lt;/strong&gt;: Roche.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.esnips.com/doc/01feaab0-d115-4957-b20f-d3d905e429a4/mCRC_Bogota_Noviembre_2009.ppt-[Modo-de-compatibilidad]"&gt;Terapia sistémica en cáncer de colon y recto metastásico (diapositivas, en .pdf, 6.5 MB)&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4134568493372182092-469930267998309274?l=mlmconferencias.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://mlmconferencias.blogspot.com/feeds/469930267998309274/comments/default' title='Enviar comentarios'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4134568493372182092&amp;postID=469930267998309274' title='0 comentarios'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/469930267998309274'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/469930267998309274'/><link rel='alternate' type='text/html' href='http://mlmconferencias.blogspot.com/2009/11/terapia-sistemica-en-cancer-de-colon-y.html' title='Terapia sistémica en Cáncer de Colon y Recto Metastásico'/><author><name>Mauricio Lema Medina MD</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='24' src='http://1.bp.blogspot.com/_y9jkl9x1Ivo/Ska2ADzwPoI/AAAAAAAABeM/tibbbu8yvdk/S220/MLM27062009.jpg'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://4.bp.blogspot.com/_y9jkl9x1Ivo/Sw663VgWakI/AAAAAAAABtQ/kIgkSnXTmVA/s72-c/mCRC_Bogot%C3%A1_2511200901.jpg' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4134568493372182092.post-5100407945597153771</id><published>2009-11-22T08:13:00.000-08:00</published><updated>2009-11-22T08:26:31.765-08:00</updated><title type='text'>Introduction to the Basics of Signal Transduction</title><content type='html'>&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://3.bp.blogspot.com/_y9jkl9x1Ivo/SwllFfZOJmI/AAAAAAAABtI/ONPtVKGxUfE/s1600/MTTC200901.jpg"&gt;&lt;img style="cursor:pointer; cursor:hand;width: 288px; height: 400px;" src="http://3.bp.blogspot.com/_y9jkl9x1Ivo/SwllFfZOJmI/AAAAAAAABtI/ONPtVKGxUfE/s400/MTTC200901.jpg" border="0" alt=""id="BLOGGER_PHOTO_ID_5406963972636026466" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;7th Latin American Molecular Targeted Therapy Council Meeting, Quito, Ecuador.&lt;br /&gt;Date: 20 November 2009, Place: Sheraton Hotel, Quito, Ecuador.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.esnips.com/doc/0ce0d052-03ab-4d46-a735-75577b87e797/STP_MLema_MTTC_2009_ExtendedCut.ppt-[Modo-de-compatibilidad]"&gt;Introduction to the Basics of Signal Transduction&lt;/a&gt; (pdf, 4.5 MB)&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4134568493372182092-5100407945597153771?l=mlmconferencias.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://mlmconferencias.blogspot.com/feeds/5100407945597153771/comments/default' title='Enviar comentarios'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4134568493372182092&amp;postID=5100407945597153771' title='0 comentarios'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/5100407945597153771'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/5100407945597153771'/><link rel='alternate' type='text/html' href='http://mlmconferencias.blogspot.com/2009/11/introduction-to-basics-of-signal.html' title='Introduction to the Basics of Signal Transduction'/><author><name>Mauricio Lema Medina MD</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='24' src='http://1.bp.blogspot.com/_y9jkl9x1Ivo/Ska2ADzwPoI/AAAAAAAABeM/tibbbu8yvdk/S220/MLM27062009.jpg'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://3.bp.blogspot.com/_y9jkl9x1Ivo/SwllFfZOJmI/AAAAAAAABtI/ONPtVKGxUfE/s72-c/MTTC200901.jpg' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4134568493372182092.post-4688559416961537917</id><published>2009-10-19T10:44:00.000-07:00</published><updated>2009-10-19T11:17:57.697-07:00</updated><title type='text'>XV Curso de actualización en cáncer</title><content type='html'>&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://1.bp.blogspot.com/_y9jkl9x1Ivo/StylrkMs10I/AAAAAAAABqM/OKA3LyJISwU/s1600-h/MC19102009.jpg"&gt;&lt;img style="cursor:pointer; cursor:hand;width: 400px; height: 256px;" src="http://1.bp.blogspot.com/_y9jkl9x1Ivo/StylrkMs10I/AAAAAAAABqM/OKA3LyJISwU/s400/MC19102009.jpg" border="0" alt=""id="BLOGGER_PHOTO_ID_5394368621552916290" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;En el marco del XV Curso de actualización en cáncer de Medicáncer - Medellín - se me encomendaron 4 temas:&lt;br /&gt;1. Diagnóstico y enfoque inicial de pacientes con cáncer hematológico&lt;br /&gt;2. Avances en sindrome mielodisplásico&lt;br /&gt;3. Evolución histórica del tratamiento de la leucemia mieloide crónica (conferencia también impartida en Montería en 08 de Octubre de 2009)&lt;br /&gt;4. Clase magistral de linfomas No Hodgkin.&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Sitio&lt;/span&gt;: Centro Comercial San Diego, Medellín&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.esnips.com/doc/5ea1af78-0fc1-441d-99bc-b45c0dad160a/EventoMC_2009"&gt;Ponencias Mauricio Lema Medina en XV Curso de actualización en cáncer: Cáncer Hematológico&lt;/a&gt; (PowerPoint 97-2003, 20 MB)&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4134568493372182092-4688559416961537917?l=mlmconferencias.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://mlmconferencias.blogspot.com/feeds/4688559416961537917/comments/default' title='Enviar comentarios'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4134568493372182092&amp;postID=4688559416961537917' title='0 comentarios'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/4688559416961537917'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/4688559416961537917'/><link rel='alternate' type='text/html' href='http://mlmconferencias.blogspot.com/2009/10/xv-curso-de-actualizacion-en-cancer.html' title='XV Curso de actualización en cáncer'/><author><name>Mauricio Lema Medina MD</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='24' src='http://1.bp.blogspot.com/_y9jkl9x1Ivo/Ska2ADzwPoI/AAAAAAAABeM/tibbbu8yvdk/S220/MLM27062009.jpg'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://1.bp.blogspot.com/_y9jkl9x1Ivo/StylrkMs10I/AAAAAAAABqM/OKA3LyJISwU/s72-c/MC19102009.jpg' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4134568493372182092.post-2513484792028866181</id><published>2009-09-13T11:21:00.001-07:00</published><updated>2009-09-13T11:37:52.160-07:00</updated><title type='text'>Conversatorio del estudio CRYSTAL en Bogotá</title><content type='html'>&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://1.bp.blogspot.com/_y9jkl9x1Ivo/Sq047eyYjMI/AAAAAAAABnc/RAaO_2OsTqQ/s1600-h/CrystalBogot%C3%A110092009.jpg"&gt;&lt;img style="cursor:pointer; cursor:hand;width: 400px; height: 295px;" src="http://1.bp.blogspot.com/_y9jkl9x1Ivo/Sq047eyYjMI/AAAAAAAABnc/RAaO_2OsTqQ/s400/CrystalBogot%C3%A110092009.jpg" border="0" alt=""id="BLOGGER_PHOTO_ID_5381019724305435842" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Fecha&lt;/span&gt;: 10 Septiembre 2009&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Lugar&lt;/span&gt;: Bogotá - Restaurante Casa Santa Clara - Monserrate&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Evento&lt;/span&gt;: Conversatorio auspiciado por Merck. Se presentó el estudio CRYSTAL (Mauricio Lema). Moderada por el Dr. Rafael Tejada (Instituto Nacional de Cancerología, Bogotá). Las debilidades del estudio Crystal fueron presentadas por el Dr. Pedro Ramos (Instituto Nacional de Cancerología, Bogotá). También se presentó el estudio CELIM&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Conferencia&lt;/span&gt;: Conversatorio sobre los estudios CRYSTAL y CELIM&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Comentario&lt;/span&gt;: Asistieron prominentes oncólogos clínicos, cirujanos oncólogos, cirujanos hepatobiliares y fellows de oncología de Bogotá. &lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Referencias&lt;/span&gt;&lt;br /&gt;1. Van Cutsem E, Kohne CH, Hitre E et al. Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer &lt;span style="font-weight:bold;"&gt;N Engl J Med&lt;/span&gt; 2009 360: 1408-1417.&lt;br /&gt;2. Bechstein WO, Lang H, Köhne C, et al. Resectability and agreement between surgeons: Review of CT and MR scan of the CELIM study: (Multicenter randomized trial of cetuximab/FOLFOX versus cetuximab/FOLFIRI in unresectable liver metastases. &lt;span style="font-weight:bold;"&gt;J Clin Oncol&lt;/span&gt; 27:15s, 2009 (suppl; abstr 4091).&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.esnips.com/doc/2bd2a4f2-1812-4012-9850-07a975786aa2/CRYSTAL_Bogota_ppt2003"&gt;Estudio CRYSTAL&lt;/a&gt; (pdf, 0.8 MB)&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4134568493372182092-2513484792028866181?l=mlmconferencias.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://mlmconferencias.blogspot.com/feeds/2513484792028866181/comments/default' title='Enviar comentarios'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4134568493372182092&amp;postID=2513484792028866181' title='0 comentarios'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/2513484792028866181'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/2513484792028866181'/><link rel='alternate' type='text/html' href='http://mlmconferencias.blogspot.com/2009/09/conversatorio-del-estudio-crystal-en.html' title='Conversatorio del estudio CRYSTAL en Bogotá'/><author><name>Mauricio Lema Medina MD</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='24' src='http://1.bp.blogspot.com/_y9jkl9x1Ivo/Ska2ADzwPoI/AAAAAAAABeM/tibbbu8yvdk/S220/MLM27062009.jpg'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://1.bp.blogspot.com/_y9jkl9x1Ivo/Sq047eyYjMI/AAAAAAAABnc/RAaO_2OsTqQ/s72-c/CrystalBogot%C3%A110092009.jpg' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4134568493372182092.post-4143976941702651979</id><published>2009-09-13T11:17:00.001-07:00</published><updated>2009-09-13T11:34:04.491-07:00</updated><title type='text'>Quimioterapia en cáncer gástrico</title><content type='html'>&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://2.bp.blogspot.com/_y9jkl9x1Ivo/Sq03Rn9ADuI/AAAAAAAABnE/TGgPGDrb8Ig/s1600-h/ChemotherapyInGastricCancer09092009.jpg"&gt;&lt;img style="cursor:pointer; cursor:hand;width: 400px; height: 301px;" src="http://2.bp.blogspot.com/_y9jkl9x1Ivo/Sq03Rn9ADuI/AAAAAAAABnE/TGgPGDrb8Ig/s400/ChemotherapyInGastricCancer09092009.jpg" border="0" alt=""id="BLOGGER_PHOTO_ID_5381017905699753698" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Fecha&lt;/span&gt;: 09 Septiembre 2009&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Lugar&lt;/span&gt;: Medellín - Hotel Intercontinental&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Evento&lt;/span&gt;: Reunión auspiciada por Roche, liderada por el Dr. James Giraldo.&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Conferencia&lt;/span&gt;: Quimioterapia en cáncer gástrico. Evidencia y actitudes&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Comentario&lt;/span&gt;: Revisión de la terapia sistémica en cáncer gástrico para cirujanos del Hospital San Rafael de Itaguí - incluyendo cirugía gastrointestinal, y cirugía oncológica. &lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.esnips.com/doc/d32a61fb-26f6-4d7e-a91b-9079126e4c3d/ChemotherapyInGastricCancer"&gt;Quimioterapia en cáncer gástrico&lt;/a&gt; (pdf, 1.2 MB)&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4134568493372182092-4143976941702651979?l=mlmconferencias.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://mlmconferencias.blogspot.com/feeds/4143976941702651979/comments/default' title='Enviar comentarios'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4134568493372182092&amp;postID=4143976941702651979' title='0 comentarios'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/4143976941702651979'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/4143976941702651979'/><link rel='alternate' type='text/html' href='http://mlmconferencias.blogspot.com/2009/09/quimioterapia-en-cancer-gastrico.html' title='Quimioterapia en cáncer gástrico'/><author><name>Mauricio Lema Medina MD</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='24' src='http://1.bp.blogspot.com/_y9jkl9x1Ivo/Ska2ADzwPoI/AAAAAAAABeM/tibbbu8yvdk/S220/MLM27062009.jpg'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://2.bp.blogspot.com/_y9jkl9x1Ivo/Sq03Rn9ADuI/AAAAAAAABnE/TGgPGDrb8Ig/s72-c/ChemotherapyInGastricCancer09092009.jpg' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4134568493372182092.post-6921918989234940024</id><published>2009-09-13T11:04:00.000-07:00</published><updated>2009-09-13T11:16:08.925-07:00</updated><title type='text'>Terapia sistémica en cáncer renal metastásico - Evidencia y propuesta hacia una secuencia terapéutica óptima</title><content type='html'>&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://2.bp.blogspot.com/_y9jkl9x1Ivo/Sq023tQ0PYI/AAAAAAAABm8/OWQtIIVCML8/s1600-h/mRCCparaUrologos08092009def.jpg"&gt;&lt;img style="cursor:pointer; cursor:hand;width: 400px; height: 296px;" src="http://2.bp.blogspot.com/_y9jkl9x1Ivo/Sq023tQ0PYI/AAAAAAAABm8/OWQtIIVCML8/s400/mRCCparaUrologos08092009def.jpg" border="0" alt=""id="BLOGGER_PHOTO_ID_5381017460448443778" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Fecha&lt;/span&gt;: 08 Septiembre 2009&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Lugar&lt;/span&gt;: Medellín - Hotel Intercontinental&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Evento&lt;/span&gt;: Conferencia del Capítulo de Antioquia de la Sociedad Colombiana de Urología&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Conferencia&lt;/span&gt;: Avances en terapia sistémica en cáncer renal metastásico&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Comentari&lt;/span&gt;o: Se presentó a una audiencia de 25 urólogos de Antioquia. También hubo presentación del Dr. Jaime Cajigas del Hospital Militar de Bogotá.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.esnips.com/doc/afb54f25-026d-4d4f-a2cc-0229a2a698e8/mRCC_Urología_2009-def"&gt;Terapia sistémica en cáncer renal metastásico - para urólogos&lt;/a&gt; (pdf, 2.6 MB)&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4134568493372182092-6921918989234940024?l=mlmconferencias.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://mlmconferencias.blogspot.com/feeds/6921918989234940024/comments/default' title='Enviar comentarios'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4134568493372182092&amp;postID=6921918989234940024' title='0 comentarios'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/6921918989234940024'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/6921918989234940024'/><link rel='alternate' type='text/html' href='http://mlmconferencias.blogspot.com/2009/09/terapia-sistemica-en-cancer-renal.html' title='Terapia sistémica en cáncer renal metastásico - Evidencia y propuesta hacia una secuencia terapéutica óptima'/><author><name>Mauricio Lema Medina MD</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='24' src='http://1.bp.blogspot.com/_y9jkl9x1Ivo/Ska2ADzwPoI/AAAAAAAABeM/tibbbu8yvdk/S220/MLM27062009.jpg'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://2.bp.blogspot.com/_y9jkl9x1Ivo/Sq023tQ0PYI/AAAAAAAABm8/OWQtIIVCML8/s72-c/mRCCparaUrologos08092009def.jpg' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4134568493372182092.post-6797258448082031900</id><published>2009-09-13T10:57:00.000-07:00</published><updated>2009-09-13T11:04:18.345-07:00</updated><title type='text'>Avances en el tratamiento de cáncer renal metastásico</title><content type='html'>&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://1.bp.blogspot.com/_y9jkl9x1Ivo/Sq0z_3lq37I/AAAAAAAABms/vJskV34_z90/s1600-h/mRCCIbagu%C3%A903092009.jpg"&gt;&lt;img style="cursor:pointer; cursor:hand;width: 400px; height: 285px;" src="http://1.bp.blogspot.com/_y9jkl9x1Ivo/Sq0z_3lq37I/AAAAAAAABms/vJskV34_z90/s400/mRCCIbagu%C3%A903092009.jpg" border="0" alt=""id="BLOGGER_PHOTO_ID_5381014302124335026" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Fecha&lt;/span&gt;: 03 Septiembre 2009&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Lugar&lt;/span&gt;: Ibagué (Tolima) - Auditorio Alfonso López Pumarejo&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Evento&lt;/span&gt;: Décimotercer simposio de Avances en Cáncer&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Conferencia&lt;/span&gt;: Terapia sistémica en cáncer renal metastásico&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Comentario&lt;/span&gt;: Conferencia presentada a un auditorio mixto de profesionales de la salud, y profesionales de la salud en formación. &lt;br /&gt;Auspiciado por: Roche&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.esnips.com/doc/f05534a9-1e44-4056-8113-42c37473dae8/mRCC_2009_NoEspecialistasParaPublicar"&gt;Cáncer renal metastásico - para no especialistas&lt;/a&gt; (pdf, 2.2 MB)&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4134568493372182092-6797258448082031900?l=mlmconferencias.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://mlmconferencias.blogspot.com/feeds/6797258448082031900/comments/default' title='Enviar comentarios'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4134568493372182092&amp;postID=6797258448082031900' title='0 comentarios'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/6797258448082031900'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/6797258448082031900'/><link rel='alternate' type='text/html' href='http://mlmconferencias.blogspot.com/2009/09/avances-en-el-tratamiento-de-cancer.html' title='Avances en el tratamiento de cáncer renal metastásico'/><author><name>Mauricio Lema Medina MD</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='24' src='http://1.bp.blogspot.com/_y9jkl9x1Ivo/Ska2ADzwPoI/AAAAAAAABeM/tibbbu8yvdk/S220/MLM27062009.jpg'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://1.bp.blogspot.com/_y9jkl9x1Ivo/Sq0z_3lq37I/AAAAAAAABms/vJskV34_z90/s72-c/mRCCIbagu%C3%A903092009.jpg' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4134568493372182092.post-7774519758117508614</id><published>2009-08-30T16:22:00.000-07:00</published><updated>2009-08-30T17:01:04.951-07:00</updated><title type='text'>Post ASCO 2009 - Highlights I</title><content type='html'>&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://1.bp.blogspot.com/_y9jkl9x1Ivo/SpsSjWAWnoI/AAAAAAAABmc/EPcUZ0stzVs/s1600-h/iPARP1.jpg"&gt;&lt;img style="cursor:pointer; cursor:hand;width: 400px; height: 276px;" src="http://1.bp.blogspot.com/_y9jkl9x1Ivo/SpsSjWAWnoI/AAAAAAAABmc/EPcUZ0stzVs/s400/iPARP1.jpg" border="0" alt=""id="BLOGGER_PHOTO_ID_5375910978608602754" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Fecha&lt;/span&gt;: 28 Agosto 2009&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Lugar&lt;/span&gt;: Santa Martha - Irotama&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Evento&lt;/span&gt;: 4to Post ASCO / ASH&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Conferencia&lt;/span&gt;: ASCO 2009 - Highlights I&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Comentario&lt;/span&gt;: Se presentó a la comunidad oncológica colombiana (miembros de las Sociedad Colombiana de Hematología y Oncología) la conferencia Highlights I  sobre los hallazgos más relevantes del Congreso ASCO 2009 realizado en Orlando (Fl, USA) en Mayo de 2009. Los temas asignados para mi conferencia incluyeron: Cáncer de mama, cáncer de colon y recto, cáncer de ano, cáncer gastrointestinal no colorrectal, melanomas y sarcomas.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.esnips.com/doc/103231f9-1142-486b-944e-e5fc9031b4e4/ASCO-2009---Highlights-I---Lema---Mama---Gastrointestinal---Melanoma---Sarcoma"&gt;ASCO Highlights I - Mama, Gastrointestinal, Melanoma y Sarcoma&lt;/a&gt; (pdf, 4.5 MB)&lt;br /&gt;&lt;a href="http://www.esnips.com/doc/acb81a50-fc36-4dd7-ad7f-411c11053989/PostASCO2009"&gt;Listado de Absracts seleccionados para la conferencia&lt;/a&gt; (doc, 352 kB)&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4134568493372182092-7774519758117508614?l=mlmconferencias.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://mlmconferencias.blogspot.com/feeds/7774519758117508614/comments/default' title='Enviar comentarios'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4134568493372182092&amp;postID=7774519758117508614' title='0 comentarios'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/7774519758117508614'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/7774519758117508614'/><link rel='alternate' type='text/html' href='http://mlmconferencias.blogspot.com/2009/08/post-asco-2009-highlights-i.html' title='Post ASCO 2009 - Highlights I'/><author><name>Mauricio Lema Medina MD</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='24' src='http://1.bp.blogspot.com/_y9jkl9x1Ivo/Ska2ADzwPoI/AAAAAAAABeM/tibbbu8yvdk/S220/MLM27062009.jpg'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://1.bp.blogspot.com/_y9jkl9x1Ivo/SpsSjWAWnoI/AAAAAAAABmc/EPcUZ0stzVs/s72-c/iPARP1.jpg' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4134568493372182092.post-737948653870944047</id><published>2009-08-02T16:40:00.000-07:00</published><updated>2009-08-02T16:48:28.147-07:00</updated><title type='text'>Nuevas terapias en cáncer de mama quimiorresistentes</title><content type='html'>&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://4.bp.blogspot.com/_y9jkl9x1Ivo/SnYk1yRkWoI/AAAAAAAABlE/mMNkKfnM7iM/s1600-h/Ixabepilona.jpg"&gt;&lt;img style="cursor:pointer; cursor:hand;width: 400px; height: 300px;" src="http://4.bp.blogspot.com/_y9jkl9x1Ivo/SnYk1yRkWoI/AAAAAAAABlE/mMNkKfnM7iM/s400/Ixabepilona.jpg" border="0" alt=""id="BLOGGER_PHOTO_ID_5365516512505649794" /&gt;&lt;/a&gt;&lt;br /&gt;Figura 1. Este sería el árbol de decisión para el tratamiento de cáncer de mama metastásico quimiorresistente&lt;br /&gt;&lt;br /&gt;Fecha: 31 de Julio 2009, Hotel El Prado - Barranquilloa, Colombia&lt;br /&gt;&lt;br /&gt;Conferencia: Nuevas terapias en cáncer de mama quimiorresistentes&lt;br /&gt;&lt;br /&gt;Público objeto: Después de darla no me quedó claro... No era definido.&lt;br /&gt;&lt;br /&gt;Auspiciado por Bristol Myers Squibb.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.esnips.com/doc/41bdb5e1-d189-4319-9f48-bd4ebda37108/NuevosMedicamentosEnCaMamaMetastasicoQuimioResistente31072009"&gt;Presentación en Acrobat&lt;/a&gt; (1.3 MB)&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4134568493372182092-737948653870944047?l=mlmconferencias.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://mlmconferencias.blogspot.com/feeds/737948653870944047/comments/default' title='Enviar comentarios'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4134568493372182092&amp;postID=737948653870944047' title='0 comentarios'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/737948653870944047'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/737948653870944047'/><link rel='alternate' type='text/html' href='http://mlmconferencias.blogspot.com/2009/08/nuevas-terapias-en-cancer-de-mama.html' title='Nuevas terapias en cáncer de mama quimiorresistentes'/><author><name>Mauricio Lema Medina MD</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='24' src='http://1.bp.blogspot.com/_y9jkl9x1Ivo/Ska2ADzwPoI/AAAAAAAABeM/tibbbu8yvdk/S220/MLM27062009.jpg'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://4.bp.blogspot.com/_y9jkl9x1Ivo/SnYk1yRkWoI/AAAAAAAABlE/mMNkKfnM7iM/s72-c/Ixabepilona.jpg' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4134568493372182092.post-5709871330537046110</id><published>2009-07-29T19:26:00.000-07:00</published><updated>2009-08-02T17:04:41.889-07:00</updated><title type='text'>Bevacizumab en Cáncer Renal Metastásico</title><content type='html'>&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://3.bp.blogspot.com/_y9jkl9x1Ivo/SnEFEqrZhAI/AAAAAAAABgU/VsDvzLzfksE/s1600-h/mRCC.jpg"&gt;&lt;img style="cursor:pointer; cursor:hand;width: 400px; height: 296px;" src="http://3.bp.blogspot.com/_y9jkl9x1Ivo/SnEFEqrZhAI/AAAAAAAABgU/VsDvzLzfksE/s400/mRCC.jpg" border="0" alt=""id="BLOGGER_PHOTO_ID_5364074208908903426" /&gt;&lt;/a&gt;&lt;br /&gt;Figura 1. Este sería el árbol de decisión para el tratamiento de cáncer renal metastásico.&lt;br /&gt;&lt;br /&gt;Fecha: 28 de Julio 2009, Restaurante El Herbario - Medellín, Colombia&lt;br /&gt;&lt;br /&gt;Conferencia: Terapia sistémica en carcinoma de riñón metastásico&lt;br /&gt;&lt;br /&gt;Público objeto: Oncólogos de Medellín.&lt;br /&gt;&lt;br /&gt;Auspiciado por Roche.&lt;br /&gt;&lt;a href="http://www.esnips.com/doc/a603d4c9-6539-4d68-8fd6-48720031d731/mRCC_2009"&gt;mRCC_2009&lt;/a&gt; (pdf, 3.5 MB)&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4134568493372182092-5709871330537046110?l=mlmconferencias.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://mlmconferencias.blogspot.com/feeds/5709871330537046110/comments/default' title='Enviar comentarios'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4134568493372182092&amp;postID=5709871330537046110' title='0 comentarios'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/5709871330537046110'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/5709871330537046110'/><link rel='alternate' type='text/html' href='http://mlmconferencias.blogspot.com/2009/07/bevacizumab-en-cancer-renal-metastasico.html' title='Bevacizumab en Cáncer Renal Metastásico'/><author><name>Mauricio Lema Medina MD</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='24' src='http://1.bp.blogspot.com/_y9jkl9x1Ivo/Ska2ADzwPoI/AAAAAAAABeM/tibbbu8yvdk/S220/MLM27062009.jpg'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://3.bp.blogspot.com/_y9jkl9x1Ivo/SnEFEqrZhAI/AAAAAAAABgU/VsDvzLzfksE/s72-c/mRCC.jpg' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4134568493372182092.post-9200882622157068022</id><published>2009-07-20T16:58:00.001-07:00</published><updated>2009-07-20T17:16:04.940-07:00</updated><title type='text'>Quimioterapia adyuvante en cáncer de colon</title><content type='html'>&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://1.bp.blogspot.com/_y9jkl9x1Ivo/Skl72VFgbRI/AAAAAAAABe8/RJyp-QxxUww/s1600-h/Moertel.jpg"&gt;&lt;img style="cursor:pointer; cursor:hand;width: 400px; height: 297px;" src="http://1.bp.blogspot.com/_y9jkl9x1Ivo/Skl72VFgbRI/AAAAAAAABe8/RJyp-QxxUww/s400/Moertel.jpg" border="0" alt=""id="BLOGGER_PHOTO_ID_5352945805409938706" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Detalles&lt;/span&gt;&lt;br /&gt;Quimioterapia adyuvante en cáncer de colon. Hotel Santa Clara, Cartagena - Julio 4 de 2009 - a oncólogos de Colombia. Auspiciado por Roche.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.esnips.com/doc/b9e63f96-cf6e-4898-8af6-1ce668c35658/CaColonAdyuvanteRoche03072009Def2"&gt;Documento en pdf 3 MB&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4134568493372182092-9200882622157068022?l=mlmconferencias.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://mlmconferencias.blogspot.com/feeds/9200882622157068022/comments/default' title='Enviar comentarios'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4134568493372182092&amp;postID=9200882622157068022' title='0 comentarios'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/9200882622157068022'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/9200882622157068022'/><link rel='alternate' type='text/html' href='http://mlmconferencias.blogspot.com/2009/07/quimioterapia-adyuvante-en-cancer-de.html' title='Quimioterapia adyuvante en cáncer de colon'/><author><name>Mauricio Lema Medina MD</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='24' src='http://1.bp.blogspot.com/_y9jkl9x1Ivo/Ska2ADzwPoI/AAAAAAAABeM/tibbbu8yvdk/S220/MLM27062009.jpg'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://1.bp.blogspot.com/_y9jkl9x1Ivo/Skl72VFgbRI/AAAAAAAABe8/RJyp-QxxUww/s72-c/Moertel.jpg' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4134568493372182092.post-1446098360263867242</id><published>2009-06-29T18:17:00.000-07:00</published><updated>2009-07-20T16:58:04.649-07:00</updated><title type='text'>Revisión del CRYSTAL</title><content type='html'>&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://4.bp.blogspot.com/_y9jkl9x1Ivo/Skln4msK4wI/AAAAAAAABes/mFXM9HdLWg0/s1600-h/CRYSTALCELIM01072009.jpg"&gt;&lt;img style="cursor:pointer; cursor:hand;width: 400px; height: 248px;" src="http://4.bp.blogspot.com/_y9jkl9x1Ivo/Skln4msK4wI/AAAAAAAABes/mFXM9HdLWg0/s400/CRYSTALCELIM01072009.jpg" border="0" alt=""id="BLOGGER_PHOTO_ID_5352923854262690562" /&gt;&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;Conversatorio sobre los estudios CRYSTAL y CELIM en formato Pro / Contra con Mauricio Luján, moderado por Pedro Reyes. Auspiciado por Merck Serono.&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Referencias&lt;/span&gt;&lt;br /&gt;1. Van Cutsem E, Kohne CH, Hitre E et al. Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer &lt;span style="font-weight:bold;"&gt;N Engl J Med&lt;/span&gt; 2009 360: 1408-1417.&lt;br /&gt;2. Bechstein WO, Lang H, Köhne C, et al. Resectability and agreement between surgeons: Review of CT and MR scan of the CELIM study: (Multicenter randomized trial of cetuximab/FOLFOX versus cetuximab/FOLFIRI in unresectable liver metastases.  &lt;span style="font-weight:bold;"&gt;J Clin Oncol&lt;/span&gt; 27:15s, 2009 (suppl; abstr 4091).&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.esnips.com/doc/1f038126-839b-444e-9fcd-b31c590b315a/Crystal_Presentation"&gt;Documento en pdf 0.7 MB&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4134568493372182092-1446098360263867242?l=mlmconferencias.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://mlmconferencias.blogspot.com/feeds/1446098360263867242/comments/default' title='Enviar comentarios'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4134568493372182092&amp;postID=1446098360263867242' title='0 comentarios'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/1446098360263867242'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/1446098360263867242'/><link rel='alternate' type='text/html' href='http://mlmconferencias.blogspot.com/2009/06/revision-del-crystal.html' title='Revisión del CRYSTAL'/><author><name>Mauricio Lema Medina MD</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='24' src='http://1.bp.blogspot.com/_y9jkl9x1Ivo/Ska2ADzwPoI/AAAAAAAABeM/tibbbu8yvdk/S220/MLM27062009.jpg'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://4.bp.blogspot.com/_y9jkl9x1Ivo/Skln4msK4wI/AAAAAAAABes/mFXM9HdLWg0/s72-c/CRYSTALCELIM01072009.jpg' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4134568493372182092.post-5899861110162252540</id><published>2009-04-12T15:32:00.000-07:00</published><updated>2009-05-12T11:59:56.660-07:00</updated><title type='text'>7mo Simposio de Coloproctologia - Quimioterapia en cáncer metastásico de colon y recto</title><content type='html'>&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://1.bp.blogspot.com/_y9jkl9x1Ivo/SeJtKQlfdJI/AAAAAAAABTs/uT8OX7sUpEY/s1600-h/afiche_outlines_SCPL09.jpg"&gt;&lt;img style="cursor:pointer; cursor:hand;width: 280px; height: 400px;" src="http://1.bp.blogspot.com/_y9jkl9x1Ivo/SeJtKQlfdJI/AAAAAAAABTs/uT8OX7sUpEY/s400/afiche_outlines_SCPL09.jpg" border="0" alt=""id="BLOGGER_PHOTO_ID_5323937732523685010" /&gt;&lt;/a&gt;&lt;br /&gt;7mo Simposio de Coloproctología; el 15 y 16 de Mayo 2009; en el hotel Intercontinental, Medellín, Colombia.&lt;br /&gt;&lt;br /&gt;Conferencia: Terapia sistémica en carcinoma metastásico de colon y recto.&lt;br /&gt;&lt;br /&gt;Público objeto: Coloproctólogos y personal de la salud no especializado.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.esnips.com/doc/00612701-26d1-4934-85f3-da17b0a7bb71/CRC_ASCO2008_Def"&gt;Quimioterapia en cáncer metastásico de colon y recto - Memorias (90 kB, pdf)&lt;/a&gt;&lt;br /&gt;&lt;a href="http://www.esnips.com/doc/1bb28a97-50e6-4266-80a6-21a15a07e52e/mCRCMedellín2009_VersiónDefinitiva"&gt;Diapositivas (2.5 MB, pdf)&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4134568493372182092-5899861110162252540?l=mlmconferencias.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://mlmconferencias.blogspot.com/feeds/5899861110162252540/comments/default' title='Enviar comentarios'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4134568493372182092&amp;postID=5899861110162252540' title='0 comentarios'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/5899861110162252540'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/5899861110162252540'/><link rel='alternate' type='text/html' href='http://mlmconferencias.blogspot.com/2009/04/7mo-simposio-de-coloproctologia.html' title='7mo Simposio de Coloproctologia - Quimioterapia en cáncer metastásico de colon y recto'/><author><name>Mauricio Lema Medina MD</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='24' src='http://1.bp.blogspot.com/_y9jkl9x1Ivo/Ska2ADzwPoI/AAAAAAAABeM/tibbbu8yvdk/S220/MLM27062009.jpg'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://1.bp.blogspot.com/_y9jkl9x1Ivo/SeJtKQlfdJI/AAAAAAAABTs/uT8OX7sUpEY/s72-c/afiche_outlines_SCPL09.jpg' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4134568493372182092.post-4665611677806113392</id><published>2009-02-15T15:25:00.000-08:00</published><updated>2009-02-15T19:17:03.562-08:00</updated><title type='text'>Avances en terapia sistémica de cáncer del pulmón de células no pequeñas avanzado</title><content type='html'>&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://2.bp.blogspot.com/_y9jkl9x1Ivo/SZjWLmSlBLI/AAAAAAAAA8o/5MU3rf07-1Q/s1600-h/NSCLCTailoringGraph02.jpg"&gt;&lt;img style="cursor:pointer; cursor:hand;width: 400px; height: 360px;" src="http://2.bp.blogspot.com/_y9jkl9x1Ivo/SZjWLmSlBLI/AAAAAAAAA8o/5MU3rf07-1Q/s400/NSCLCTailoringGraph02.jpg" border="0" alt=""id="BLOGGER_PHOTO_ID_5303224055974134962" /&gt;&lt;/a&gt;&lt;br /&gt;Figura 1. Este sería el árbol de decisión ideal, que requiere de establecer la presencia de mutación en el EGFR (Epidermal Growth Factor Receptor) en pacientes no fumadores para poder ofrecerles un inhibidor de tirosina kinasa en primera línea (Erlotinib en Colombia) - como consecuencia de los resultados del estudio IPASS.&lt;br /&gt;&lt;br /&gt;&lt;a onblur="try {parent.deselectBloggerImageGracefully();} catch(e) {}" href="http://2.bp.blogspot.com/_y9jkl9x1Ivo/SZjVRTJiCkI/AAAAAAAAA8Y/8N0RVdpiqWM/s1600-h/NSCLCTailoringGraph.jpg"&gt;&lt;img style="cursor:pointer; cursor:hand;width: 400px; height: 342px;" src="http://2.bp.blogspot.com/_y9jkl9x1Ivo/SZjVRTJiCkI/AAAAAAAAA8Y/8N0RVdpiqWM/s400/NSCLCTailoringGraph.jpg" border="0" alt=""id="BLOGGER_PHOTO_ID_5303223054403504706" /&gt;&lt;/a&gt;&lt;br /&gt;Figura 2. Este es el árbol de decisión que he seguido hasta la fecha. Ya incorpora los resultados del FLEX para algunos pacientes.&lt;br /&gt;&lt;a href="http://www.esnips.com/doc/8025bb06-33d7-4dcc-b793-c1d68380d414/NSCLCaTailoringGraph02"&gt;Diapositivas de las figuras 1 y 2 en Powerpoint (83 KB, ppt 2007)&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;br /&gt;Fecha: 14 de Febrero 2009, Hotel Irotama - Santa Martha, Colombia&lt;br /&gt;&lt;br /&gt;Conferencia: Avances en terapia sistémica en carcinoma de pulmón de células no pequeñas avanzado.&lt;br /&gt;&lt;br /&gt;Público objeto: Cirujanos de tórax de Colombia. &lt;br /&gt;&lt;br /&gt;En el lanzamiento en Colombia de Avastin (Bevacizumab) en cáncer del pulmón de células no pequeñas avanzado. Organizado por Roche.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.esnips.com/doc/c0c10320-4dae-4283-8ac6-5731e35fbad0/NSCLCStaMartha2009_definitiva"&gt;Presentación en PowerPoint (7.2 MB, ppt 97)&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4134568493372182092-4665611677806113392?l=mlmconferencias.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://mlmconferencias.blogspot.com/feeds/4665611677806113392/comments/default' title='Enviar comentarios'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4134568493372182092&amp;postID=4665611677806113392' title='0 comentarios'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/4665611677806113392'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/4665611677806113392'/><link rel='alternate' type='text/html' href='http://mlmconferencias.blogspot.com/2009/02/avances-en-terapia-sistemica-de-cancer.html' title='Avances en terapia sistémica de cáncer del pulmón de células no pequeñas avanzado'/><author><name>Mauricio Lema Medina MD</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='24' src='http://1.bp.blogspot.com/_y9jkl9x1Ivo/Ska2ADzwPoI/AAAAAAAABeM/tibbbu8yvdk/S220/MLM27062009.jpg'/></author><media:thumbnail xmlns:media='http://search.yahoo.com/mrss/' url='http://2.bp.blogspot.com/_y9jkl9x1Ivo/SZjWLmSlBLI/AAAAAAAAA8o/5MU3rf07-1Q/s72-c/NSCLCTailoringGraph02.jpg' height='72' width='72'/><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4134568493372182092.post-5449767693056101819</id><published>2008-11-26T12:44:00.000-08:00</published><updated>2009-02-15T15:50:19.422-08:00</updated><title type='text'>Molecular Targeted Therapy in Brain Tumors</title><content type='html'>6th Latin American Molecular Targeted Therapy Council Meeting, Buenos Aires, Argentina.&lt;br /&gt;Date: 21 November 2008, Place: Sheraton Hotel and Convention Center, Buenos Aires Argentina.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.esnips.com/doc/a0239199-c9d9-4251-9972-d93c6e87ecf4/Gliomas"&gt;Presentación en PowerPoint (2.4 MB - ppt 97)&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;&lt;a href="http://hemoncblog.blogspot.com/2008/11/ponencia-en-el-6th-latin-american-mttc.html"&gt;Script&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4134568493372182092-5449767693056101819?l=mlmconferencias.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://mlmconferencias.blogspot.com/feeds/5449767693056101819/comments/default' title='Enviar comentarios'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4134568493372182092&amp;postID=5449767693056101819' title='0 comentarios'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/5449767693056101819'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/5449767693056101819'/><link rel='alternate' type='text/html' href='http://mlmconferencias.blogspot.com/2008/11/molecular-targeted-therapy-in-brain.html' title='Molecular Targeted Therapy in Brain Tumors'/><author><name>Mauricio Lema Medina MD</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='24' src='http://1.bp.blogspot.com/_y9jkl9x1Ivo/Ska2ADzwPoI/AAAAAAAABeM/tibbbu8yvdk/S220/MLM27062009.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4134568493372182092.post-1979475679726790179</id><published>2008-10-22T16:18:00.000-07:00</published><updated>2009-02-15T15:50:50.703-08:00</updated><title type='text'>ARNO-95</title><content type='html'>Fecha:  22 Octubre 2008, Hotel Dann Carlton, Medellín&lt;br /&gt;Conversatorio sobre el &lt;a href="http://www.esnips.com/doc/c516244c-45d4-414c-a539-bdb7b4b6ba9a/ARNO95"&gt;ARNO-95&lt;/a&gt; dirigido por Fernando Herazo, auspiciado por AstraZeneca.&lt;br /&gt;Objetivos: Describir el ARNO-95 con sus fortalezas (las debilidades están a cargo de Mauricio Luján Piedrahita).&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.esnips.com/doc/bd4a4c78-5e5a-4880-803b-5606ebda362f/ARNO-95"&gt;Presentación en PowerPoint (0.5 MB, ppt 2007)&lt;/a&gt;&lt;br /&gt;&lt;br /&gt;Referencia&lt;br /&gt;- Kaufmann M, Jonat W, Hilfrich J, et al. Improved Overall Survival in Postmenopausal Women With Early Breast Cancer After Anastrozole Initiated After Treatment With Tamoxifen Compared With Continued Tamoxifen: The ARNO 95 Study. J Clin Oncol 2007 25: 2664-2670&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4134568493372182092-1979475679726790179?l=mlmconferencias.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://mlmconferencias.blogspot.com/feeds/1979475679726790179/comments/default' title='Enviar comentarios'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4134568493372182092&amp;postID=1979475679726790179' title='0 comentarios'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/1979475679726790179'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/1979475679726790179'/><link rel='alternate' type='text/html' href='http://mlmconferencias.blogspot.com/2008/10/arno-95.html' title='ARNO-95'/><author><name>Mauricio Lema Medina MD</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='24' src='http://1.bp.blogspot.com/_y9jkl9x1Ivo/Ska2ADzwPoI/AAAAAAAABeM/tibbbu8yvdk/S220/MLM27062009.jpg'/></author><thr:total>0</thr:total></entry><entry><id>tag:blogger.com,1999:blog-4134568493372182092.post-2892851874552977797</id><published>2008-10-19T19:34:00.000-07:00</published><updated>2009-02-15T15:53:27.645-08:00</updated><title type='text'>Quimioterapia paliativa</title><content type='html'>Fecha: 24 Octubre 2008&lt;br /&gt;Evento de &lt;span style="font-weight:bold;"&gt;Medicáncer&lt;/span&gt; 2008, Medellín.&lt;br /&gt;&lt;br /&gt;&lt;span style="font-weight:bold;"&gt;Objetivo(s&lt;/span&gt;)&lt;br /&gt;Discutir sobre los desenlaces relevantes en la oncología con fines paliativos: calidad de vida o cantidad de vida.&lt;br /&gt;&lt;br /&gt;Revisar la evidencia más relevante sobre el incremento en cantidad de vida con quimioterapia paliativa en cáncer incurable&lt;br /&gt;&lt;br /&gt;Listar la (escasa) evidencia disponible sobre calidad de vida con quimioterapia paliativa en cáncer incurable&lt;br /&gt;&lt;br /&gt;Establecer los criterios para la utilización de quimioterapia paliativa, duración del tratamiento, número de líneas tradicionalmente utilizados, así como los criterios de terminación de la misma.&lt;br /&gt;&lt;br /&gt;&lt;a href="http://www.esnips.com/doc/b308834c-5eac-49f6-964b-01347f560a80/Quimioterapia-paliativa"&gt;Presentación en PowerPoint (2.6 MB, ppt 97)&lt;/a&gt;&lt;div class="blogger-post-footer"&gt;&lt;img width='1' height='1' src='https://blogger.googleusercontent.com/tracker/4134568493372182092-2892851874552977797?l=mlmconferencias.blogspot.com' alt='' /&gt;&lt;/div&gt;</content><link rel='replies' type='application/atom+xml' href='http://mlmconferencias.blogspot.com/feeds/2892851874552977797/comments/default' title='Enviar comentarios'/><link rel='replies' type='text/html' href='http://www.blogger.com/comment.g?blogID=4134568493372182092&amp;postID=2892851874552977797' title='0 comentarios'/><link rel='edit' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/2892851874552977797'/><link rel='self' type='application/atom+xml' href='http://www.blogger.com/feeds/4134568493372182092/posts/default/2892851874552977797'/><link rel='alternate' type='text/html' href='http://mlmconferencias.blogspot.com/2008/10/quimioterapia-paliativa.html' title='Quimioterapia paliativa'/><author><name>Mauricio Lema Medina MD</name><email>noreply@blogger.com</email><gd:image rel='http://schemas.google.com/g/2005#thumbnail' width='32' height='24' src='http://1.bp.blogspot.com/_y9jkl9x1Ivo/Ska2ADzwPoI/AAAAAAAABeM/tibbbu8yvdk/S220/MLM27062009.jpg'/></author><thr:total>0</thr:total></entry></feed>
